Navigation Links
Mersana Therapeutics Appoints Michael A. Metzger as EVP & COO
Date:4/20/2011

anchise. He also led the US co-development and co-promotion deal with Ironwood Pharmaceuticals for Linaclotide. Prior to Forest, Mr. Metzger was Vice President of Corporate Development at Onconova Therapeutics, where he was responsible for the company's business development and financial initiatives. He also served as Managing Director at MESA Partners, a venture capital firm focused on healthcare and IT companies. He serves as a member of the Board of Directors and Chairman of the Finance Committee of Response Genetics, Inc., a company focused on the development and commercialization of molecular diagnostic tests for cancer. Mr. Metzger earned his BA from George Washington University and an MBA in Finance from New York University's Stern School of Business.

About Mersana Therapeutics, Inc.

Mersana, a privately held, venture backed company, utilizes its proprietary polymer conjugate platform, called  Fleximer®, to transform existing and experimental anti-cancer agents into new, patentable drugs with superior pharmaceutical properties. The key component of Mersana's Fleximer platform is a novel, biodegradable and bio-inert material that can be chemically linked to small molecules and biologics. Mersana's clinical pipeline includes XMT-1001, a Fleximer-camptothecin conjugate, which is currently in Phase 1b clinical trials, as well as XMT-1107, a conjugate of Fleximer and a novel analog of fumagillin, which is currently in Phase 1 clinical trials and partnered on a worldwide basis with Teva Pharmaceuticals. Mersana's investors include Fidelity Biosciences, ProQuest Investments, Rho Ventures, Harris & Harris Group and PureTech Ventures.

Fleximer® is a trademark of Mersana Therapeutics, Inc.


'/>"/>
SOURCE Mersana Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Mersana Therapeutics Initiates Phase 1b Extension Study of XMT-1001 in Gastric Cancer and Non-Small Cell Lung Cancer
2. Mersana Therapeutics Provides Clinical Update from Ongoing Phase 1 Study of XMT-1001 in Patients with Advanced Solid Tumors
3. Mersana Therapeutics Reports Phase I Results for XMT-1001 in Patients with Solid Tumors at AACR-NCI-EORTC International Conference
4. Amicus Therapeutics Announces Transition of John F. Crowley from Chairman and Chief Executive Officer to Executive Chairman
5. CoDa Therapeutics Closes $19 Million Series B Financing Round
6. Reportlinker Adds Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017
7. Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017
8. Reportlinker Adds Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
9. Oxford BioTherapeutics Licenses BioWas POTELLIGENT® Technology for the Research and Development of its Therapeutic Antibodies in Cancer
10. Medicomp, Inc. Announces Company Purchase From United Therapeutics
11. Reportlinker Adds Pain Therapeutics - Drugs, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014  Based on its ... market, Frost & Sullivan recognizes Siemens Healthcare with ... Siemens Healthcare,s FREEZEit solution, which employs Siemens, MAGNETOM ... robust and motion-insensitive imaging. The solution,s sophistication and ... of body MRI imaging in the U.S. market. ...
(Date:7/22/2014)... 22, 2014 Sanofi Pasteur, the vaccines division of ... today that the first lots of Fluzone ® (Influenza ... released by the U.S. Food and Drug Administration (FDA) for ... the first of at least 65 million doses of seasonal ... to U.S. health care providers and pharmacies in August. ...
(Date:7/22/2014)... 22, 2014 Galmed Pharmaceuticals Ltd. (Nasdaq: ... on the development and commercialization of a once-daily, oral ... gallstones, announced today that the U.S. Food and Drug ... or IND, application.  Such clearance will permit Galmed to ... the United States for the ...
Breaking Medicine Technology:Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 2Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 3Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 4Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 2Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 3Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 4Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 5Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 6Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 7Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 2Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 3Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 4
(Date:7/22/2014)... 2014) The American Society of Hematology (ASH) ... of California Los Angeles with the 2014 E. ... homeostasis, including the discovery of the iron-regulatory hormone hepcidin ... award, named after the Nobel Prize Laureate and past ... achievements in hematology that have represented a paradigm shift ...
(Date:7/22/2014)... research at the University of Utah,s John A. Moran ... of Eye Research (ISER) as the recipient of the ... Award in Retina Research., The award recognizes lifetime achievement ... contribution to the understanding of vitreoretinal diseases or disorders. ... ISER Biennial Meeting in San Francisco, where Marc will ...
(Date:7/22/2014)... Angeles, CA (PRWEB) July 22, 2014 As ... replied to a caller request to name her favorite beauty ... Ripa went on to say that “ Botox has ... spends in the makeup chair preparing for her various, daily ... my eyelashes,” explained Ms. Ripa (see: goo.gl/shmTQM). , “I think ...
(Date:7/22/2014)... American Conference on Lung Cancer (LALCA 2014) will be ... , Lung Cancer is still the leading cause of ... on the success of the previous conferences in Chile, ... discuss the science and advances in the treatment and ... Latin America in particular. , With tobacco being the ...
(Date:7/22/2014)... Los Angeles, CA (PRWEB) July 22, 2014 ... leads the way in providing resources, educational tools and ... that tell the stories of prevention, treatment and recovery. ... drama BLACK BOX will spotlight some of these resources ... Mental Health Services Administration helpline and treatment website at ...
Breaking Medicine News(10 mins):Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 2Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 3Health News:University of Utah researcher Robert Marc receives Paul Kayser International Award 2Health News:Celebrity Botox: Kelly Ripa Confesses to Getting Botox Injections 2Health News:ABC’s BLACK BOX Spotlights Mental Health and Available Resources in Upcoming Episode 2
... A drug whose clinical benefit in treating multiple sclerosis was ... Food and Drug Administration on January 22 and is now ... is the first therapy for multiple sclerosis that can be ... to treat impaired walking, a debilitating symptom of the disease ...
... ... renewed its multi year relationship with Seventh Generation, the leading global brand of green ... paper towels. , ... Hong Kong, China (April 1, 2010) – Serendipity House Limited, Hong Kong’s leading provider ...
... ... a new survey of U.S. healthcare organizations suggests that while organizations are updating their ... ... the healthcare industry prepares for a major shift to electronic health records (EHRs) over ...
... ... Techniques Are Impacting the Face of the Senior Care Industry , ... Newport Beach, Calif. (PRWEB) April 5, ... on how elder care marketers grow their businesses. The Elder Care Marketing Industry Report, ...
... discovered retrovirus, xenotropic murine leukemia virus-related virus (XMRV), has ... of conflicting data concerning XMRV, standardized diagnostic testing is ... and to determine whether it plays a role in ... the April issue of Urology is a ...
... Research on antibodies may aid vaccine development , MONDAY, April ... insight into how the body fights off HIV, a finding ... the virus, which causes AIDS. , At the moment, there,s ... develop a vaccine. HIV remains an extremely stubborn enemy. , ...
Cached Medicine News:Health News:Clinical benefit of multiple sclerosis drug discovered at Rush University Medical Center 2Health News:Clinical benefit of multiple sclerosis drug discovered at Rush University Medical Center 3Health News:Serendipity House Limited, the Leading Provider of Natural and Organic Products in Hong Kong, Renews Multi-year Relationship with Seventh Generation 2Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 2Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 3Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 4Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 5Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 6Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 7Health News:New Study on Elder Care Marketing Reveals Fresh Insights in Targeting Aging Population 2Health News:New Study on Elder Care Marketing Reveals Fresh Insights in Targeting Aging Population 3Health News:New investigation supports correlation between XMRV and prostate cancer 2Health News:Scientists Find Clues to How the Body Fights Off HIV 2
... hormone (FSH) is a glycoprotein hormone ... Like hCG, LH and TSH, the ... dimer consisting of alpha- and beta-subunits. ... by gonadotropin-releasing hormone (GnRH) from the ...
Complete product line for typing all classical HLA loci including A, B, C DRA, DRB1, DRB3, DRB4, DRB5, DQA, DQB1, DPA1, and DPB1....
... II Direct to High Res SSP kits provide ... a single tray. Locus specific typing on a ... saving time. , Straight from genomic DNA ... low resolution typing , Allele level typing with ...
... Class I Direct to High Res SSP kits provide ... single tray. Locus specific typing on a single tray ... Straight from genomic DNA to high resolution results, ... level typing with a single tray , Unique reaction ...
Medicine Products: